Bumseok Kim Selected Research

amlexanox (Aphthasol)

11/2020	Dual TBK1/IKKε inhibitor amlexanox mitigates palmitic acid-induced hepatotoxicity and lipoapoptosis in vitro.
1/2020	Dual TBK1/IKKɛ inhibitor amlexanox attenuates the severity of hepatotoxin-induced liver fibrosis and biliary fibrosis in mice.
12/2019	Amlexanox ameliorates acetaminophen-induced acute liver injury by reducing oxidative stress in mice.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Bumseok Kim Research Topics

Disease

26	Infections 09/2022 - 10/2002
14	Fibrosis (Cirrhosis) 01/2022 - 01/2015
12	Inflammation (Inflammations) 01/2022 - 07/2012
9	Keratitis 12/2008 - 10/2002
8	Non-alcoholic Fatty Liver Disease 01/2022 - 01/2016
8	Liver Cirrhosis (Hepatic Cirrhosis) 01/2020 - 07/2014
7	Neoplasms (Cancer) 05/2022 - 01/2005
5	Virus Diseases (Viral Diseases) 01/2019 - 12/2006
5	Corneal Neovascularization 07/2017 - 10/2002
4	Liver Diseases (Liver Disease) 09/2017 - 06/2014
3	Osteoarthritis 06/2022 - 01/2021
3	COVID-19 01/2022 - 11/2020
3	Porcine Reproductive and Respiratory Syndrome (PRRS) 10/2021 - 01/2016
3	Type 2 Diabetes Mellitus (MODY) 05/2021 - 10/2018
3	Asthma (Bronchial Asthma) 01/2020 - 11/2013
3	Fatty Liver 10/2018 - 10/2016
3	Neoplasm Metastasis (Metastasis) 11/2017 - 01/2017
2	Fever (Fevers) 09/2022 - 01/2020
2	Weight Loss (Weight Reduction) 09/2022 - 01/2022
2	Arthritis (Polyarthritis) 06/2022 - 07/2012
2	Adenocarcinoma 05/2022 - 12/2011
2	Viremia 10/2021 - 05/2020
2	Thrombocytopenia (Thrombopenia) 06/2021 - 01/2020
2	Neuroinflammatory Diseases 06/2021 - 01/2019
2	Hyperglycemia 05/2021 - 11/2012
2	Brucellosis (Malta Fever) 03/2021 - 09/2018
2	Cholestasis 01/2020 - 07/2014
2	Ulcer 12/2019 - 12/2006
2	Body Weight (Weight, Body) 01/2018 - 10/2012
2	Burns 07/2017 - 01/2017
2	Wounds and Injuries (Trauma) 07/2017 - 05/2009
2	Carcinogenesis 01/2017 - 10/2013
2	Cardiovascular Diseases (Cardiovascular Disease) 06/2014 - 01/2014
2	Eye Infections 07/2005 - 10/2002
1	Stomach Neoplasms (Stomach Cancer) 05/2022
1	Communicable Diseases (Infectious Diseases) 01/2022
1	Hemorrhage 06/2021
1	Poisoning 05/2021
1	Chemical and Drug Induced Liver Injury 05/2021
1	Chronic Disease (Chronic Diseases) 01/2021
1	Acute Liver Failure (Fulminant Hepatic Failure) 01/2021

Drug/Important Bio-Agent (IBA)

12	Proteins (Proteins, Gene)FDA Link 01/2021 - 03/2004
11	CytokinesIBA 06/2021 - 08/2005
8	VaccinesIBA 01/2022 - 10/2008
7	Antiviral Agents (Antivirals)IBA 09/2021 - 12/2006
7	SmokeIBA 02/2020 - 08/2016
5	ChemokinesIBA 05/2020 - 01/2004
5	CollagenIBA 02/2020 - 05/2009
4	Interferon Type IIBA 06/2021 - 07/2014
4	InterferonsIBA 01/2020 - 07/2011
4	Vascular Endothelial Growth Factor A (Vascular Endothelial Growth Factor)IBA 01/2017 - 12/2004
4	Toll-Like Receptors (Toll-Like Receptor)IBA 04/2016 - 10/2011
3	ginsenoside Rb1IBA 06/2022 - 07/2012
3	Messenger RNA (mRNA)IBA 01/2022 - 10/2013
3	Acetaminophen (Paracetamol)FDA LinkGeneric 05/2021 - 01/2021
3	AntigensIBA 03/2021 - 09/2005
3	amlexanox (Aphthasol)FDA Link 11/2020 - 12/2019
3	Phosphotransferases (Kinase)IBA 11/2020 - 12/2019
3	Interleukin-1 Receptors (Interleukin 1 Receptor)IBA 01/2020 - 03/2004
3	Nicotine FDA Link 01/2020 - 01/2017
3	EnzymesIBA 07/2015 - 10/2002
3	Interferon-alpha (Interferon Alfa)IBA 12/2011 - 01/2005
3	DNA (Deoxyribonucleic Acid)IBA 12/2006 - 07/2005
2	Neutralizing AntibodiesIBA 09/2022 - 10/2021
2	Pharmaceutical PreparationsIBA 09/2021 - 03/2019
2	FlagellinIBA 05/2021 - 01/2020
2	Aspartate Aminotransferases (Aspartate Transaminase)IBA 01/2021 - 01/2017
2	Insulin-Like Growth Factor I (IGF-1)IBA 01/2021 - 01/2016
2	p38 Mitogen-Activated Protein KinasesIBA 01/2021 - 01/2018
2	Palmitic Acid (Hexadecanoic Acid)IBA 11/2020 - 10/2018
2	GinsenosidesIBA 03/2020 - 01/2014
2	OvalbuminIBA 01/2020 - 11/2013
2	Hypoglycemic Agents (Hypoglycemics)IBA 08/2019 - 11/2012
2	Particulate MatterIBA 10/2018 - 06/2014
2	Cathepsin DIBA 10/2017 - 02/2017
2	AlkaliesIBA 07/2017 - 01/2017
2	Matrix Metalloproteinase 9 (Gelatinase B)IBA 01/2017 - 10/2002
2	Tissue Inhibitor of Metalloproteinase-1IBA 10/2016 - 10/2002
2	LigandsIBA 05/2015 - 09/2005
2	Chemokine CCL2 (Monocyte Chemoattractant Protein 1)IBA 11/2013 - 12/2006
2	Interleukin-18 (Interleukin 18)IBA 07/2011 - 07/2005
1	Viral RNAIBA 09/2022
1	HydrogelsIBA 06/2022
1	BromidesIBA 05/2022
1	myricetinIBA 05/2022
1	mRNA VaccinesIBA 01/2022
1	Angiotensin-Converting Enzyme 2IBA 01/2022
1	LipidsIBA 01/2022
1	A-Form DNA (A-DNA)IBA 10/2021
1	asunaprevirIBA 09/2021
1	Blood Glucose (Blood Sugar)IBA 05/2021
1	Ethanol (Ethyl Alcohol)IBA 01/2021
1	Alanine (L-Alanine)FDA Link 01/2021
1	Reactive Oxygen Species (Oxygen Radicals)IBA 01/2021
1	Sodium Bicarbonate (Baking Soda)FDA LinkGeneric 01/2021
1	Membrane LipidsIBA 01/2021
1	NF-kappa B (NF-kB)IBA 01/2021

Therapy/Procedure

6	Oral Administration 01/2022 - 07/2010
4	Therapeutics 08/2019 - 10/2002
2	Ligation 07/2018 - 07/2015